(CARLSBAD, Calif.)Biotechnology company Isis Pharmaceuticals Inc. said Thursday its second-quarter loss narrowed due to greater revenue from research collaborations. Isis reported a loss of $2.2 mil...READ MORE

(CAMBRIDGE, Mass.)Drug developer Ariad Pharmaceuticals Inc. said Thursday that Senior Vice President and Chief Operating Officer Richard W. Pascoe resigned to take a position elsewhere.READ MORE

(NEW YORK)Wall Street has so far dealt with a mixed second-quarter report card for biotechnology companies, but shares continue outpacing the broader market on a mix of positive sales result...READ MORE

(NEW YORK)Shares of Genzyme Corp. fell Wednesday after the company reported positive second-quarter financial results but said plans to increase production of its genetic disorder drug Myozy...READ MORE

Among the earnings stories for Wednesday, July 23, from AP Financial News: Top stories:READ MORE

(CAMBRIDGE, Mass.)Biotechnology company Genzyme Corp. said Wednesday its second-quarter profit fell on a series of charges, though adjusted profit and revenue topped Wall Street forecasts.READ MORE

(NEW YORK)Shares throughout the biotechnology sector advanced Monday as Swiss pharmaceutical giant Roche offered to buy Genentech Inc. in potentially the biggest pharma-biotech deal of the y...READ MORE